跳至主要内容
临床试验/CTRI/2024/10/074783
CTRI/2024/10/074783尚未招募Unknown

A Clinical Study to Evaluate the Efficacy of Tatshan After Sun recovery Gel in Reducing Erythma and Inflammation after UV-B Exposure on skin

Mohb Growell Pvt Ltd1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2024年10月10日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
32
试验地点
1
主要终点
Change in Erythema with Mexameter

研究概览

简要总结

To  Evaluate the efficacy of a gel containing extract of phormidium persinicum , glyceryl glucoside ,beta glycirhettinic acid , natural alpha bisobolol in reducing erythema after UVB exposure.  

To evaluate its utility in treatment of sunburns

Day0: MED at three spots. send the volunteers with the test creams. ask them to apply the said creams twice a day for 7 days .  as the volunteers to apply

patch 1  test cream twice a day

patch 2 Calamine and liquid paraffin lotion twice a day

patch 3 Aloevera Gel twice a day

Patch 4 Blank

Day 2: once the redness is visible - measure redness with colorimeter , pigment - Mexameter, edema by Dermat, temperature -  dedicated skin temperature probe-  Pain- questionnaire, Imaging Day 3: a followup call for redness, pain Day 7: Same as Day 2 assessments

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • Having apparently healthy skin on test area, for whom the investigator considers that the compliance will be correct and who can allow irradiation slightly more than the MED.
  • Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • Having signed a Consent form.
  • Should be able to read and write (in English, Hindi or local language).
  • Having valid proof of identity and age.

排除标准

  • Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 4.Dermatological infection or pathology on the level of studied area 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Chronic illness which may influence the outcome of the study 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

结局指标

主要结局

Change in Erythema with Mexameter

时间窗: Day 2, Day 7

次要结局

  • Change in redness with colorimeter(Day 2, Day 7)
  • Change in Edema by Dermat(Day 2, Day 7)
  • Change in skin Temperature(Day 2, Day 7)

研究者

发起方
Mohb Growell Pvt Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验